CFTR and Thrombocytopenia: More importantly, our data have supported that correction of the F508del CFTR trafficking [23] are able to counteract the proinflammatory phenotype of F508del platelets and neutrophils, reflected by attenuation of thrombocytopenia, reduction of BAL neutrophils, protein, and MIP-2 levels.